World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 9 January 2017
Main ID:  NCT02748551
Date of registration: 10/04/2016
Prospective Registration: No
Primary sponsor: Moscow Clinical Scientific Center
Public title: A Comparison Laparoscopic With Open Gastric Cancer Surgery for Locally Advanced Gastric Cancer
Scientific title: Prospective Multicenter Study on Laparoscopic Gastric Cancer Surgery Compared With Open Surgery for Locally Advanced Gastric Cancer
Date of first enrolment: April 2016
Target sample size: 800
Recruitment status: Recruiting
URL:  https://clinicaltrials.gov/show/NCT02748551
Study type:  Interventional
Study design:  Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment  
Phase:  Phase 3
Countries of recruitment
Russian Federation Ukraine
Contacts
Name:     Vladimir Lyadov, MD, PhD
Address: 
Telephone:
Email:
Affiliation:  Treatment and Rehabilitation Centre of Health Ministry of Russia
Name:     Michail Lando, MD, PhD
Address: 
Telephone:
Email:
Affiliation:  Lipetsk regional oncological center
Name:     Boris Pomortsev, MD
Address: 
Telephone:
Email:
Affiliation:  Moscow Clinical Scientific Center
Name:     Igor Khatkov, MD, PhD
Address: 
Telephone:
Email:
Affiliation:  Moscow Clinical Scientific Center
Name:     Victor Kashchenko, MD, PhD
Address: 
Telephone:
Email:
Affiliation:  Federal Medical Biology Agence ?122 the name of L.Sokolov
Name:     Roman Izrailov, MD, PhD
Address: 
Telephone:
Email:
Affiliation:  Moscow Clinical Scientific Center
Name:     Igor Khathov, MD, PhD
Address: 
Telephone: 8 (495) 3042908
Email: ihatkov@gmail.com
Affiliation: 
Name:     Andrey Pavlenko, MD, PhD
Address: 
Telephone:
Email:
Affiliation:  Leningradsky oncological center
Name:     Michail Byachov, MD, PhD
Address: 
Telephone:
Email:
Affiliation:  Moscow Clinical Scientific Center
Name:     Andrey Ryabov, MD, PhD
Address: 
Telephone:
Email:
Affiliation:  P.Herzen Moscow Oncological Research Institute
Name:     Kirill Schostka, MD, PhD
Address: 
Telephone:
Email:
Affiliation:  Leningradsky oncological center
Name:     Sergey Baydo, MD, PhD
Address: 
Telephone:
Email:
Affiliation:  Lisod clinic Kiev
Name:     Michail Prostov
Address: 
Telephone:
Email:
Affiliation:  Moscow Clinical Scientific Center
Name:     Pavel Kononets, MD, PhD
Address: 
Telephone:
Email:
Affiliation:  Moscow Oncological Hospital 62
Name:     Alexey Karachun, MD, PhD
Address: 
Telephone:
Email:
Affiliation:  N. Petrov National Research Institute of Oncology
Key inclusion & exclusion criteria

Inclusion Criteria:

- ECOG 0-1

- ASA I-III

- Histologically proven cancer of the stomach cT 2-4a(clinical stage tumor), N0-3, M0
at preoperative evaluation according to the American Joint Committee on Cancer (AJCC)
Cancer Staging Manual Seventh Edition

- Preoperative examination with no distant metastasis, no significantly enlarged lymph
nodes around abdominal main artery, and tumor not a direct violation of the pancreas,
spleen and other surrounding organs

- The gastric tumors are located in the stomach, are macroscopically resectable by
subtotal or total gastrectomy with D2 lymph node dissection.

- Written informed consent

Exclusion Criteria:

- Clinically apparent distant metastasis

- Free cancer cells

- Bulky lymph node metastasis is detected by abdominal CT

- Previous treatment with radiation therapy for any tumors.

- Previous surgery for the present disease

- Pregnancy

- Psychiatric disease



Age minimum: 18 Years
Age maximum: 82 Years
Gender: Both
Health Condition(s) or Problem(s) studied
Gastric Cancer
Intervention(s)
Procedure: Open Surgery
Procedure: Laparoscopic procedures
Primary Outcome(s)
"Major" Surgical Morbidity [Time Frame: 21 days.]
Secondary Outcome(s)
3-year progression-free survival [Time Frame: 36 months]
Surgical Mortality [Time Frame: 90 days]
long-term surgical morbidity [Time Frame: 21days - 36 months after surgery]
Pain scores [Time Frame: up to 3 days after surgery]
Peri-operative blood loss [Time Frame: 1 day]
Postoperative quality of life [Time Frame: 6, 12, 18, 24, 30 and 36 months]
3-year overall survival [Time Frame: 6, 12, 18, 24, 30 and 36 months]
5-year overall survival rate [Time Frame: 6, 12, 18, 24, 30, 36, 48 and 60 months]
Extent of lymph node dissection [Time Frame: 2 weeks]
Postoperative recovery index [Time Frame: 10 days]
Secondary ID(s)
MKNC 01/2016
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history